Clinical trialNCT05171816Active, not recruitingPhase 3Interventional

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)

SponsorAstraZenecaEnrollment110Metastatic Castration-resistant Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Fred Saad, MD
University of Montreal Hospital Center
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Noel Clarke, M.D.
Christie Hospital Foundation Trust
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Chongqing, China
Research Site
Guangzhou, China
Research Site
Guangzhou, China
Research Site
Guizhou, China
Research Site
Henan, China
Research Site
Hubei, China
Research Site
Hunan, China
Research Site
Hunan, China
Research Site
Jilin City, China
Research Site
Jilin City, China
Research Site
Liaoning, China
Research Site
Nanchang, China
Research Site
Nanjing, China
Research Site
Ningbo, China
Research Site
Shanghai, China
Research Site
Shanghai, China
Research Site
Sichuan, China
Research Site
Sichuan, China
Research Site
Xi'an, China
Research Site
Zhejiang, China
Research Site
Zhejiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Abiraterone →Olaparib →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 24 Jun 2021
Primary completion: 22 Jan 2024
Completion: 5 Feb 2027
Last update posted: 18 Jun 2026
Registered enrollment: 110
Registry id: NCT05171816

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.